- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Amplia Therapeutics Ltd (ATX)
Amplia Therapeutics Ltd stock price live, this page displays ASX ATX stock exchange data. View the ATX premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Amplia Therapeutics Ltd real time stock price chart below.
What Is the Amplia Therapeutics Ltd Stock Price Today?
The Amplia Therapeutics Ltd stock price today is 0.165.
What Is the Stock Symbol for Amplia Therapeutics Ltd?
The stock symbol for Amplia Therapeutics Ltd is ""ATX.""
What Stock Exchange Does Amplia Therapeutics Ltd Trade On?
Amplia Therapeutics Ltd is listed and trades on the Sydney stock exchange.
Is Amplia Therapeutics Ltd a Good Stock to Buy?
Determining whether Amplia Therapeutics Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ATX quote. (ISIN: AU0000023822)
What Is the Amplia Therapeutics Ltd Stock Price Today?
The Amplia Therapeutics Ltd stock price today is 0.165.
What Is the Stock Symbol for Amplia Therapeutics Ltd?
The stock symbol for Amplia Therapeutics Ltd is ""ATX.""
What Stock Exchange Does Amplia Therapeutics Ltd Trade On?
Amplia Therapeutics Ltd is listed and trades on the Sydney stock exchange.
Is Amplia Therapeutics Ltd a Good Stock to Buy?
Determining whether Amplia Therapeutics Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ATX quote. (ISIN: AU0000023822)
Sydney
Currency in AUD
0.165
-0.005(-2.94%)
Closed·
Fair Value
An estimate of a Amplia Therapeutics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.163
0.175
52 wk Range
0.049
0.425
ATX Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
ATX is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Amplia Therapeutics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.1630.175
52 wk Range
0.0490.425
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
ATX Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Amplia Therapeutics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
0.420
Upside
+154.55%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Impressive gross profit margins
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Amplia Therapeutics Ltd Company Profile
Amplia Therapeutics Limited, a clinical-stage drug development company, engages in the development of focal adhesion kinase (FAK) inhibitors for cancer and fibrosis in Australia. Its product pipeline comprises Narmafotinib (AMP945), an inhibitor of FAK, which is in 1b/2a clinical trial for pancreatic cancer; and treatment of idiopathic pulmonary fibrosis, as well as ovarian cancer. It also develops AMP886 for application in oncology and chronic fibrosis indications. The company was formerly known as Innate Immunotherapeutics Limited and changed its name to Amplia Therapeutics Limited in September 2018. Amplia Therapeutics Limited was incorporated in 2000 and is based in Melbourne, Australia.
Compare ATX to Peers and Sector
Metrics to compare | ATX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipATXPeersSector | |
|---|---|---|---|---|
P/E Ratio | −12.2x | −5.1x | −0.5x | |
PEG Ratio | −1.56 | −0.18 | 0.00 | |
Price/Book | 3.8x | 2.2x | 2.6x | |
Price / LTM Sales | 21.2x | 16.8x | 3.3x | |
Upside (Analyst Target) | 154.5% | 317.0% | 38.9% | |
Fair Value Upside | Unlock | −5.0% | 5.4% | Unlock |
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 0.420
(+154.55% Upside)
Earnings
Latest Release
May 30, 2025
EPS / Forecast
-0.01 / --
Revenue / Forecast
2.38M / --
People Also Watch
FAQ
What Stock Exchange Does Amplia Therapeutics Trade On?
Amplia Therapeutics is listed and trades on the Sydney Stock Exchange stock exchange.
What Is the Stock Symbol for Amplia Therapeutics?
The stock symbol for Amplia Therapeutics is "ATX."
What Is the Amplia Therapeutics Market Cap?
As of today, Amplia Therapeutics market cap is 80.27M.
What Is Amplia Therapeutics's Earnings Per Share (TTM)?
The Amplia Therapeutics EPS (TTM) is -0.02.
From a Technical Analysis Perspective, Is ATX a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Amplia Therapeutics Stock Split?
Amplia Therapeutics has split 4 times.
How Many Employees Does Amplia Therapeutics Have?
Amplia Therapeutics has 0 employees.
What is the current trading status of Amplia Therapeutics (ATX)?
As of 30 Aug 2025, Amplia Therapeutics (ATX) is trading at a price of 0.165, with a previous close of 0.17. The stock has fluctuated within a day range of 0.163 to 0.175, while its 52-week range spans from 0.049 to 0.425.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.